We have generated Vps33ap.R500W KI mice with a mutation corresponding to the human MPSPS mutation (p.R498W) using the CRISPR/Cas9 method to understand the detailed pathogenesis and mechanism of MPSPS and to develop therapeutic strategies. The gene discussed is VPS33A; the disease is mucopolysaccharidosis-plus syndrome.